ATPO
CAS : 252930-37-3
Ref. 3D-CKA93037
| 5mg | À demander | ||
| 10mg | À demander | ||
| 25mg | À demander | ||
| 50mg | À demander | ||
| 100mg | À demander |
Informations sur le produit
Atovaquone is a medication used to treat chronic viral hepatitis and other conditions. It inhibits the synthesis of RNA by binding to the polymerase enzyme. This drug has been shown to be effective in treating patients with hepatitis and autoimmune diseases, such as lysis, cell lysis, and diagnosis. Atovaquone also has a role in the treatment of chronic HBV infection by inhibiting the production of viral DNA. Atovaquone is a prodrug that is converted into its active form, hydroxychloroquine (HCQ), by cytochrome P450 enzymes. HCQ is then converted into chloroquine (CQ) through further oxidation reactions. CQ can inhibit protein synthesis, leading to cell death by inhibiting the production of proteins vital for cell division.
ATPO has also been shown to have anti-inflammatory properties, which may be due to its inhibition of prostaglandin synthesis.
Propriétés chimiques
Question d’ordre technique sur : 3D-CKA93037 ATPO
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
